Replies to post #18747 on General Stock Ideas

[ombowstring]

Yes, $1s is what people are saying if the trial failed, but that doesn't seem likely at all given that CytoDyn and the FDA look to be cooperating with each other from all I can see.

>> More likely what we'll see is not a completely bombed trial, but a missed primary endpoint but some secondary endpoints that were met. <<

I don't think so.

Short interest down 6 million shares to 21,610,017 from 27,620,396 as of 2/12/2021 -

https://otce.finra.org/otce/equityShortInterest

That will be a lot of shares that need to be covered, bought if we get EUA.

Share price up again today.